Athira Pharma, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
ATHA on Nasdaq
Location
18706 North Creek Parkway, Suite 104, Bothell, Washington

Insiders trading volume in the past year

Athira Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Perceptive Advisors Llc Director, 10%+ Owner $12.9 M +$1.46 M +12.8% Dec 27, 2023
Mark Litton CEO, Director $477 K -$28.1 K -5.55% Feb 15, 2024
Hans Moebius Chief Medical Officer $266 K Jan 4, 2024
Andrew Gengos Cfo And Chief Business Officer $244 K -$3.52 K -1.42% Feb 14, 2024
Kevin Church Chief Scientific Officer $234 K -$7.02 K -2.92% Feb 14, 2024
Kelly A. Romano Director $195 K +$100 K +105% Jun 21, 2024
Mark Worthington General Counsel $100 K -$14 K -12.3% Feb 14, 2024
Rachel Lenington Coo And Cdo $39 K -$14 K -26.5% Feb 14, 2024
Javier San Chief Medical Officer Apr 15, 2024
Tadataka Yamada Director May 28, 2021
Grant Pickering Director May 24, 2024
Joseph Edelman Director May 24, 2024
Glenna Mileson Chief Financial Officer Jan 19, 2023
Michael A. Panzara Director May 24, 2024
Barbara Kosacz Director May 24, 2024
John M. Fluke Jr Director May 24, 2024
James A. Johnson Director May 24, 2024

Recent Insider Transactions by Companies or Individuals for Athira Pharma, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership